ASX-listed CBD / hemp companies might see increased inflows from global funds looking to play the sector. Valuation Re-rating and M&A InterestASX CBD / hemp stocks may see re-ratings as multiples expand due to a more favourable US outlook. Technology and Research Cross-OverMany Australian cannabis / biotech firms focus on medical / therapeutic cannabis, cannabinoid formulations, or derivative products. ASX Cannabis / Hemp Stocks to WatchLittle Green Pharma (ASX: LGP) — One of the first movers in Australia’s medicinal cannabis industry, with established cultivation and production facilities. Vitura Health (ASX: VIT) — Involved in CBD / medicinal cannabis distribution and digital health platforms.